References:
-----------

1. Cee Reports, 2018: [Enhancer and Transcription Factor Dynamics during Myeloid Differentiation Reveal an Early Differentiation Block in Cebpa null Progenitors](https://www.sciencedirect.com/science/article/pii/S2211124718307459?via%3Dihub#sec4.7):
    1. H3K4me1 ChIP data combined with [PARE](https://spundhir.github.io/PARE/) to predict enhancers in LSK and GMP ([GSE89767](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE89767))
    2. "We find no evidence of a pioneering function of PU.1 during late GM-lineage differentiation. Instead, we delineate a set of enhancers that gain accessibility in a CEBPA-dependent manner, suggesting a **pioneering function of CEBPA**."
    3. "CEBPA controls PU.1 levels and, unexpectedly, that the loss of CEBPA results in an early differentiation block."
    4. "PU.1 binding to enhancers is diminished in Cebpa null GM progenitors"
    5. Enhancer landscape during GM-lineage differentiation
2. JCI, 2016: [MLL-AF9â€“ and HOXA9-mediated acute myeloid leukemia stem cell self-renewal requires JMJD1C](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4767347/):
    1. HSC don't need JMJD1C but LSC need
    2. In vivo shRNA screen of MLL-AF9 target genes ([GSE75581](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE75581)). Results of shRNA screening and RNA-seq ([supplementary table](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4767347/bin/JCI82978.sd.pdf))
3. JCB, 2017: [Silencing of retrotransposons by SETDB1 inhibits the interferon response in acute myeloid leukemia](http://jcb.rupress.org/content/216/11/3535):
    1. CRISPR screening of ~300 epigenetic associated genes in human p53-deficient MLL-AF9 cells. ([GSE103411](http://jcb.rupress.org/lookup/external-ref?link_type=NCBIGEO&access_num=GSE103411&atom=%2Fjcb%2F216%2F11%2F3535.atom))
    2. Using [RepEnrich2](https://github.com/nerettilab/RepEnrich2) to calculate TE transcripts over RNA-seq and ChIP-seq
